Ning, S., Ma, S., Saleh, A. Q., Guo, L., Zhao, Z., & Chen, Y. (2018). SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma. Gastroenterol Res Pract.
Styl ChicagoNing, Shanglei, Siquan Ma, Abdul Qahar Saleh, Lingyu Guo, Zixiao Zhao, a Yuxin Chen. "SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma." Gastroenterol Res Pract 2018.
Citace podle MLANing, Shanglei, et al. "SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma." Gastroenterol Res Pract 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..